Clínica Baviera, S.A. (CBAV.MC)
EUR 31.4
(-1.26%)
EUR 31.4
(-1.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 38.96 Million EUR | 87.27% |
| 2022 | 20.8 Million EUR | -50.17% |
| 2021 | 41.75 Million EUR | -5.14% |
| 2020 | 44.01 Million EUR | -11.42% |
| 2019 | 49.69 Million EUR | 420.78% |
| 2018 | 9.54 Million EUR | 2.73% |
| 2017 | 9.28 Million EUR | -26.74% |
| 2016 | 12.67 Million EUR | 32.01% |
| 2015 | 9.6 Million EUR | -28.02% |
| 2014 | 13.34 Million EUR | 1325.07% |
| 2013 | -1.08 Million EUR | -116.2% |
| 2012 | 6.72 Million EUR | 27.46% |
| 2011 | 5.27 Million EUR | 10.37% |
| 2010 | 4.77 Million EUR | -41.22% |
| 2009 | 8.12 Million EUR | -15.19% |
| 2008 | 9.58 Million EUR | 455.0% |
| 2007 | -2.69 Million EUR | 60.27% |
| 2006 | -6.79 Million EUR | 22.13% |
| 2005 | -8.72 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -13.9 Million EUR | -135.55% |
| 2024 Q2 | -5.51 Million EUR | 60.33% |
| 2023 Q4 | 39.1 Million EUR | 26147.27% |
| 2023 Q2 | -7.46 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q3 | 149 Thousand EUR | 102.0% |
| 2023 FY | 38.96 Million EUR | 87.27% |
| 2022 Q2 | -6.23 Million EUR | -279.47% |
| 2022 Q1 | 3.47 Million EUR | -91.68% |
| 2022 FY | 20.8 Million EUR | -50.17% |
| 2022 Q4 | 20.8 Million EUR | 2428.09% |
| 2022 Q3 | 823 Thousand EUR | 113.2% |
| 2021 Q1 | 22.37 Million EUR | -49.16% |
| 2021 Q3 | 14.15 Million EUR | 1117.83% |
| 2021 Q4 | 41.75 Million EUR | 194.92% |
| 2021 Q2 | -1.39 Million EUR | -106.22% |
| 2021 FY | 41.75 Million EUR | -5.14% |
| 2020 Q1 | 44.21 Million EUR | -11.02% |
| 2020 Q2 | 11.45 Million EUR | -74.09% |
| 2020 Q3 | 34.02 Million EUR | 197.01% |
| 2020 Q4 | 44.01 Million EUR | 29.35% |
| 2020 FY | 44.01 Million EUR | -11.42% |
| 2019 Q2 | 13.3 Million EUR | -64.36% |
| 2019 FY | 49.69 Million EUR | 420.78% |
| 2019 Q3 | 47.17 Million EUR | 254.66% |
| 2019 Q4 | 49.69 Million EUR | 5.35% |
| 2019 Q1 | 37.32 Million EUR | 291.13% |
| 2018 Q2 | 11.58 Million EUR | 0.0% |
| 2018 Q4 | 9.54 Million EUR | 81.89% |
| 2018 FY | 9.54 Million EUR | 2.73% |
| 2018 Q3 | 5.24 Million EUR | -54.71% |
| 2017 Q4 | 9.28 Million EUR | 0.0% |
| 2017 FY | 9.28 Million EUR | -26.74% |
| 2017 Q2 | 13.07 Million EUR | 352.39% |
| 2017 Q1 | 2.89 Million EUR | -77.2% |
| 2016 Q4 | 12.67 Million EUR | 0.0% |
| 2016 Q2 | 7.96 Million EUR | 0.0% |
| 2016 FY | 12.67 Million EUR | 32.01% |
| 2015 FY | 9.6 Million EUR | -28.02% |
| 2015 Q2 | 13.25 Million EUR | 0.0% |
| 2015 Q4 | 9.6 Million EUR | 0.0% |
| 2014 Q2 | 4.17 Million EUR | 0.0% |
| 2014 FY | 13.34 Million EUR | 1325.07% |
| 2014 Q4 | 13.34 Million EUR | 0.0% |
| 2013 Q4 | -1.08 Million EUR | 0.0% |
| 2013 Q2 | -828 Thousand EUR | 0.0% |
| 2013 FY | -1.08 Million EUR | -116.2% |
| 2012 FY | 6.72 Million EUR | 27.46% |
| 2012 Q2 | 6.07 Million EUR | 0.0% |
| 2012 Q4 | 6.72 Million EUR | 0.0% |
| 2011 FY | 5.27 Million EUR | 10.37% |
| 2011 Q2 | 2.94 Million EUR | 0.0% |
| 2011 Q4 | 5.27 Million EUR | 0.0% |
| 2010 Q2 | -16.55 Million EUR | 0.0% |
| 2010 FY | 4.77 Million EUR | -41.22% |
| 2010 Q4 | 4.77 Million EUR | 0.0% |
| 2009 FY | 8.12 Million EUR | -15.19% |
| 2009 Q4 | 8.12 Million EUR | 0.0% |
| 2008 FY | 9.58 Million EUR | 455.0% |
| 2007 FY | -2.69 Million EUR | 60.27% |
| 2006 FY | -6.79 Million EUR | 22.13% |
| 2005 FY | -8.72 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 4.34 Million EUR | -796.398% |